Immunosuppression May Modify Performance of Biomarker-Based ARDS Phenotype Classifiers
H.M. Giannini(Lung Institute), N.J. Meyer(Pulmonary and Allergy Associates), C.A.G. Ittner(University of Pennsylvania), Ariel R. Weisman(University of Pennsylvania), R.S. Agyekum(Translational Therapeutics (United States)), Todd A. Miano(University of Pennsylvania), Brian J. Anderson(University of Pennsylvania), Tiffanie K. Jones(University of Pennsylvania), C.S. Calfee, P. Sinha, Christopher V. Cosgriff(University of Pennsylvania), John P. Reilly(University of Pennsylvania), Thomas Dunn(Translational Therapeutics (United States)), M.G.S. Shashaty(University of Pennsylvania)
Cited by 0
Related Papers
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Comprehensive mapping of immune perturbations associated with severe COVID-19
|Science Immunology|2020|806
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
|Nature Medicine|2021|521
Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared with adult and pediatric COVID-19
|Science Immunology|2021|206
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
|Journal of Clinical Investigation|2017|200